Literature DB >> 20157046

Successful use of mizoribine to treat recurrent corticosteroid-resistant palpable purpura in a patient with henoch-schonlein purpura nephritis.

Tamihiro Kawakami, Sayuri Shirai, Kenjiro Kimura, Yoshinao Soma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20157046     DOI： 10.1001/archdermatol.2009.371

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  4 in total

1.  Efficacy of mizoribine and prednisolone combination therapy in adult patients with IgA vasculitis.

Authors:  Akira Mima
Journal:  Rheumatol Int       Date:  2017-03-02       Impact factor: 2.631

2.  Low-dose corticosteroid with mizoribine might be an effective therapy for elderly-onset ISKDC grade VI IgA vasculitis.

Authors:  Hikaru Sugimoto; Shiho Matsuno; Noriko Yamanaka; Wako Yumura; Mitsuyo Itabashi; Takashi Takei
Journal:  CEN Case Rep       Date:  2020-08-04

3.  Treatment of refractory IgA vasculitis with dapsone: a systematic review.

Authors:  Keum Hwa Lee; Sung Hwi Hong; Jinhae Jun; Youngheun Jo; Woogyeong Jo; Dayeon Choi; Jeongho Joo; Guhyun Jung; Sunghee Ahn; Andreas Kronbichler; Michael Eisenhut; Jae Il Shin
Journal:  Clin Exp Pediatr       Date:  2019-09-24

Review 4.  Individualized medication based on pharmacogenomics and treatment progress in children with IgAV nephritis.

Authors:  Xuerong Yang; Qi Li; Yuanyuan He; Yulian Zhu; Rou Yang; Xiaoshi Zhu; Xi Zheng; Wei Xiong; Yong Yang
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.